HROW (Harrow, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Harrow, Inc. Common Stock (HROW) is a publicly traded Healthcare sector company. As of May 21, 2026, HROW trades at $30.58 with a market cap of $1.15B and a P/E ratio of -79.81. HROW moved +0.88% today. Year to date, HROW is -43.69%; over the trailing twelve months it is +9.94%. Its 52-week range spans $20.85 to $59.23. Analyst consensus is strong buy with an average price target of $67.17. Rallies surfaces HROW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns HROW stock?
Hedge funds tracked by Rallies that own HROW include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Harrow, Inc. Common Stock.
HROW Key Metrics
Key financial metrics for HROW
Metric
Value
Price
$30.58
Market Cap
$1.15B
P/E Ratio
-79.81
EPS
$-0.39
Dividend Yield
0.00%
52-Week High
$59.23
52-Week Low
$20.85
Volume
81
Avg Volume
0
Revenue (TTM)
$268.68M
Net Income
$-14.96M
Gross Margin
74.11%
Top Hedge Funds Holding HROW
Panagora Asset holds 86.10K shares of HROW, changed +121.73% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own HROW include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Harrow, Inc. Common Stock.
Does Rallies show 13F holders for HROW?
Yes. Rallies tracks hedge fund and 13F ownership data for HROW, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HROW research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HROW. It does not provide personalized investment advice.
